In this video, we explore a mystery object sent by a fan with guesses including a landmine, a gas mask, and a 60-year-old MRE ...

Alumis Inc. (Nasdaq: ALMS), a clinical-stage biopharmaceutical company developing next-generation targeted therapies for patients with immune-mediated diseases, today reported financial results for ...

Q3 2025 Earnings Call November 13, 2025 9:00 AM ESTCompany ParticipantsPanna Sharma - President, CEO & DirectorDavid ...

Monopar Therapeutics Inc. (“Monopar” or the “Company”) (Nasdaq: MNPR), a clinical‐stage biopharmaceutical company developing innovative treatments for patients with unmet medical needs, today ...

Sjögren’s Disease (SD) In October 2025, Vor Bio’s and its collaborator, RemeGen Co., Ltd, reported positive top-line Phase 3 results from the study of telitacicept in Sjögren’s disease in China. The ...

Aprea Therapeutics, Inc. (Nasdaq: APRE) ("Aprea", or the "Company"), a clinical-stage biopharmaceutical company developing innovative treatments that exploit specific cancer cell vulnerabilities while ...

Background Unprecedented, forced displacement, especially from conflict and war areas, requires addressing resultant mental ...

Resch has spent 2025 building her off-court roster for the Tempo, the WNBA’s first franchise outside the US. Just who will ...

Cypherpunk Technologies Inc., previously known as Leap Therapeutics, Inc. (Nasdaq:LPTX), a company developing novel therapies for patients with cancer and implementing a digital asset treasury ...

Imunon Inc (IMNN) reports significant progress in its pivotal phase 3 trial for ovarian cancer, while navigating financial ...

Restaurant Brands International Inc. ("RBI" or the "Company") (TSX: QSR) (NYSE: QSR) announced today that Restaurant Brands ...

Introduction Globally, enteric pathogens have been associated with poor child growth and development. Our aim was to assess ...